In this study, we synthesis a mitochondria-targeted contrast agent named triphenylphosphine-2,2,6,6-tetramethylpiperidine-1-oxyl (TPP-TEMPOL) to protect the kidney from the damage induced by rhabdomyolysis. At the same time, measured the T1 changes by MRI.
This abstract and the presentation materials are available to members only; a login is required.